Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

Recruiting now · Phase 3

Conditions studied: Hypertension, Dyslipidemia

In brief

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

Key facts

Study ID

NCT06643130

Run by

JW Pharmaceutical

People needed

162

Starts

2024-12-02

Expected to finish

2026-04-01

Last updated by the study team

2025-09-09

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with hypertension and dyslipidemia

You may not qualify if…

• The subject not meet the specified msBP and LDL-C level

Where it is running

• Gangdong Sacred Heart Hospital — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.